Send the following on WhatsApp
Continue to ChatOcugen's COVID-19 co-vaccine development partner, Bharat Biotech, shares second interim results that include 100% protection against serious diseases, including hospitalization https://beforeits.news/ocugens-covid-19-co-vaccine-development-partner-bharat-biotech-shares-second-interim-results-that-include-100-protection-against-serious-diseases-including-hospitalization.html